News
Video
Understanding Further Treatment Opportunities for Patients With Polycythemia Vera
Pharmacy Times® interviewed Brady Stein, MD, MHSc, of the Feinberg School of Medicine at Northwestern University, on the implications of the results of his research on further investigation and treatment opportunities for patients with polycythemia vera.
Pharmacy Times® interviewed Brady Stein, an associate professor of medicine in hematology and oncology at the Feinberg School of Medicine at Northwestern University, on his presentation at the 62nd ASH Annual Meeting and Exposition. The presentation discusses a multicenter, noninterventional, prospective observational study of patients with polycythemia vera (PV) in US clinical practices, specifically in relation to mortality and causes of death.
In this video, Stein explains the implications of the study results on further investigation and treatment opportunities for patients with PV.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
FDA Approves Linvoseltamab-Gcpt for Treatment of Relapsed or Refractory Multiple Myeloma
